Diabetes Drug Delivery Methods - Market and Technologies

This Frost & Sullivan research service titled Drug Delivery for Diabetes-Market and Technologies provides an overview of advancements in drug delivery technologies in diabetes. It also provides a description of the revenues generated by present insulin delivery methods along with a complete analysis of key market drivers, restraints and trends prevailing in the European market. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: insulin syringes, insulin pens, insulin pumps and inhaled insulin.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

- Insulin Syringes

- Insulin Pens

- Insulin Pumps

- Inhaled Insulin

Technologies

The following technologies are covered in this research:

- Inhaled insulin

- Oral insulin

- Transdermal insulin

- Nanotechnology

- Diabetes vaccine

- Gene therapy

Market Overview

Non-invasive Insulin Delivery to Significantly Improve Diabetes Management
The growing demand for non-invasive delivery of insulin, particularly inhaled insulin, is leading to increased focus on the diabetes drug delivery market in Europe. Moreover, due to the irregularity exhibited by a significant number of patients in following insulin therapy, companies are pursuing insulin delivery methods that involve reduced pain, thereby facilitating compliance with the therapy. While various non-invasive delivery methods such as oral insulin, transdermal delivery and nanotechnology are still under research, the overall drug discovery market is anticipated to exhibit strong growth.
For diabetic patients using insulin injections, who are faced with issues such as infections, improper administration of insulin and uncontrolled blood glucose, alternate insulin delivery methods are likely to offer tremendous benefits, remarks the analyst of this research service. In addition, with the ability of inhaled insulin to offer glycaemic control comparable to insulin injections, such advantages are likely to promote market growth.

Competitive Pricing Key to Market Growth
Despite the potential of the market, long-term safety and efficacy of pulmonary delivery of insulin are factors expected to pose a challenge to market growth. While the Food and Drug Administration (FDA) as well as the European Medical Evaluation Agency (EMEA) have approved Exubera (the first inhaled insulin to enter the market), occurrences of pulmonary fibrosis during clinical trials are causing concerns about its safety. Hence, pharmaceutical companies involved in the research of inhaled insulin devices will need to focus on long-term safety of emerging insulin delivery methods.
At the same time, novel insulin delivery methods, such as transdermal insulin delivery, are anticipated to gain prominence across Europe The reimbursement of inhaled insulin, which relies on its cost effectiveness as well as patient compliance, is likely to be hampered by its high prices, says the analyst. Hence, the advantages of convenience, safety and accuracy of inhaled insulin in comparison to conventional insulin, will need to be proved to justify the high costs. SHOW LESS READ MORE >

1. Executive Summary

- 1. Executive Summary of the Diabetes Drug Delivery Methods-Market and Technologies.--
- 1. Market Overview
- 2. Introduction

- 1. Research Methodology

- - 1. Research Methodology for the Diabetes Drug Delivery Methods- Market and Technologies

- 2. Exchange Rates

- - 1. Currency Conversion

- 3. History Of Insulin

- - 1. History
- 3. Overview of Insulin

- 1. Insulins

- - 1. Animal Insulins

- - 2. Semi-synthetic and Genetically Engineered Insulins
- 4. Insulin Delivery

- 1. Current Delivery Devices - Technology

- - 1. Insulin Syringes

- - 2. Insulin Jet Injectors

- - 3. Insulin Pumps

- - 4. Insulin Pens

- 2. Current Delivery Devices - Market Engineering Research

- - 1. Market Overview

- - 2. Market Engineering Measurements

- - 3. Market Drivers for Insulin Syringes Market

- - 4. Market Restraints for Insulin Syringes Market

- - 5. Market Drivers for Insulin Pumps and Jet Injectors Market

- - 6. Market Restraints for Insulin Pumps and Jet Injectors Market

- - 7. Market Drivers for Insulin Pens Market

- - 8. Market Restraints for Insulin Pens Market

- - 9. Competitive Structure

- - 10. Market Share Analysis

- - 11. Revenue Forecasts
- 5. Novel Insulin Delivery Devices

- 1. Introduction

- - 1. Advancements in Diabetes Therapy

- 2. Drug Delivery - Future Technologies--
- 1. Inhaled Insulin

- - 2. Oral Insulin

- - 3. Transdermal Insulin

- - 4. Nanotechnology

- - 5. Diabetes Vaccine

- - 6. Gene Therapy
- 6. Market Engineering Research for Inhaled Insulins

- 1. Industry Challenges

- - 1. Strategic Factors- 2. Europe

- - 1. Market Overview

- - 2. Market Engineering Measurements

- - 3. Market Drivers

- - 4. Market Restraints

- - 5. Competitive Structure

- - 6. Revenue Forecasts

- 3. The United Kingdom

- - 1. Market Overview

- - 2. Market Engineering Measurements

- - 3. Market Drivers

- - 4. Market Restraints

- - 5. Revenue Forecasts

- 4. Germany

- - 1. Market Overview

- - 2. Market Engineering Measurements

- - 3. Market Drivers

- - 4. Market Restraints

- - 5. Revenue Forecasts

- 5. France

- - 1. Market Overview

- - 2. Market Engineering Measurements

- - 3. Market Drivers

- - 4. Market Restraints

- - 5. Revenue Forecasts

- 6. Spain

- - 1. Market Overview

- - 2. Market Engineering Measurements

- - 3. Market Drivers

- - 4. Market Restraints

- - 5. Revenue Forecasts

- 7. Italy

- - 1. Market Overview

- - 2. Market Engineering Measurements

- - 3. Market Drivers

- - 4. Market Restraints

- - 5. Revenue Forecasts

- 8. Scandinavia

- - 1. Market Overview

- - 2. Market Engineering Measurements

- - 3. Market Drivers

- - 4. Market Restraints

- - 5. Revenue Forecasts

- 9. Benelux

- - 1. Market Overview

- - 2. Market Engineering Measurements

- - 3. Market Drivers--
- 4. Market Restraints

- - 5. Revenue Forecasts
- 7. Strategic Recommendations for the European Inhaled Insulin Market

- 1. Market Engineering Strategic Recommendations

- - 1. Market Engineering Strategy
- 8. Frost & Sullivan Awards

- 1. 2006 Frost & Sullivan Awards

- - 1. Frost & Sullivan Awards for the European Diabetes Drug Delivery Market

- - 2. Technology Innovation Award

- - 3. Product Line Strategy Award

- - 4. Market Leadership Award
- 9. Database of Key Industry Participants

- 1. Key Industry Participants

- - 1. Major Participants
- 10. Appendix

- 1. Decision Support Database--
- 1. Diabetes Incidence

- - 2. Diabetes Prevalence

- - 3. Diabetes Prevalence Percent

- - 4. Obesity Prevalence

- - 5. Total Healthcare Expenditure

List Of Figures

Chapter 2

- Diabetes Drug Delivery-Market and Technologies: Exchange Rates (Europe), 2006

Chapter 3

- Diabetes Drug delivery Methods-Market and Technologies: Position of amino acids in Bovine, Porcine and Human Insulins (World), 2005
- Diabetes Drug delivery Methods-Market and Technologies: Amino acid changes in Humalog (World), 2005

Chapter 4

- Diabetes Drug Delivery - Market and Technologies: SWOT analysis of Subcutaneous Insulin Injections (Europe), 2005
- Diabetes Drug Delivery - Market and Technologies: Novo Nordisk Insulin Pens (Europe), 2005
- Diabetes Drug Delivery - Market and Technologies: Eli Lilly & Co. Insulin Pens (Europe), 2005
- Diabetes Drug Delivery - Market and Technologies: Sanofi-Aventis Insulin Pens (Europe), 2005
- Diabetes Drug Delivery - Market and Technologies: Owen Mumford Insulin Pens (Europe), 2005
- Diabetes Drug Delivery - Market and Technologies: Market Drivers for insulin syringes in Order of Impact (Europe), 2003-2009
- Diabetes Drug Delivery - Market and Technologies: Market Restraints for insulin syringes in Order of Impact (Europe), 2006-2012
- Diabetes Drug Delivery - Market and Technologies: Market Drivers for insulin Pumps and Jet Injectors in Order of Impact (Europe), 2005-2012
- Diabetes Drug Delivery - Market and Technologies: Market Restraints for insulin Pumps and Jet Injectors in Order of Impact (Europe), 2005-2012
- Diabetes Drug Delivery - Market and Technologies: Market Drivers for insulin Pens in Order of Impact (Europe), 2005-2012
- Diabetes Drug Delivery - Market and Technologies: Market Restraints for insulin Pens in Order of Impact (Europe), 2005-2012
- Diabetes Drug Delivery - Market and Technologies: Competitive Structure (Europe), 2005
- Diabetes Drug Delivery - Market and Technologies: Revenue Forecast by Product Type (Europe), 2002-2012

Chapter 5

- Diabetes Drug Delivery Methods-Market and Technologies: SWOT analysis of Exubera Inhaled Insulin (Europe), 2005
- Diabetes Drug Delivery Methods-Market and Technologies: Various pulmonary insulins (World), 2005
- Diabetes Drug Delivery Methods-Market and Technologies: Dosing Chart for Exubera (Europe), 2005
- Diabetes Drug Delivery Methods-Market and Technologies: SWOT analysis of AERx Inhaled Insulin (Europe), 2005

Chapter 6

- Diabetes Drug Delivery Methods-Market and Technologies: Pricing and Reimbursement strategies (Europe), 2005
- Diabetes Drug Delivery Methods-Market and Technologies: Market Drivers for inhaled insulin Ranked in Order of Impact (Europe), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Restraints for inhaled insulins Ranked in Order of Impact (Europe), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Competitive Structure (Europe), 2005
- Diabetes Drug Delivery Methods-Market and Technologies: Revenue Forecasts for Inhaled Insulins (Europe), 2006-2012
- Inhaled Insulins Market: Revenue Forecasts - Country wise (Europe), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Drivers for inhaled insulins Ranked in Order of Impact (United Kingdom), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Restraints for inhaled insulins Ranked in Order of Impact (United Kingdom), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Revenue Forecasts for Inhaled Insulins (United Kingdom), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Drivers for inhaled insulins Ranked in Order of Impact (Germany), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Restraints for inhaled insulins Ranked in Order of Impact (Germany), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Revenue Forecasts for Inhaled Insulins (Germany), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Drivers for inhaled insulins Ranked in Order of Impact (France), 2008-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Restraints for inhaled insulins Ranked in Order of Impact (France), 2008-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Revenue Forecasts for Inhaled Insulins (France), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Drivers for inhaled insulins Ranked in Order of Impact (Spain), 2008-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Restraints for inhaled insulins Ranked in Order of Impact (Spain), 2008-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Revenue Forecasts for Inhaled Insulins (Spain), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Drivers for inhaled insulins Ranked in Order of Impact (Italy), 2008-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Restraints for inhaled insulins Ranked in Order of Impact (Italy), 2008-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Revenue Forecasts for Inhaled Insulins (Italy), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Drivers for inhaled insulins Ranked in Order of Impact (Scandinavia), 2008-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Restraints for inhaled insulins Ranked in Order of Impact (Scandinavia), 2008-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Revenue Forecasts for Inhaled Insulins (Scandinavia), 2006-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Drivers for inhaled insulins Ranked in Order of Impact (Benelux), 2008-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Market Restraints for inhaled insulins Ranked in Order of Impact (Benelux), 2008-2012
- Diabetes Drug Delivery Methods-Market and Technologies: Revenue Forecasts for Inhaled Insulins (Benelux), 2006-2012

Chapter 7

- Diabetes Drug Delivery Methods-Market and Technologies: Eliminate-Reduce-Raise-Create Grid, (Europe), 2005
- Diabetes Drug Delivery Methods-Market and Technologies: Strategic Recommendations for inhaled insulins (Europe), 2005
- Inhaled Insulins Market: Revenue Forecasts (Europe), 2006-2012